Cargando…

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor

Ten new triterpenoid compounds with structure diversity of the C-17 side-chain, including nine tirucallanes, named xylocarpols A–E (1–5) and agallochols A–D (6–9), and an apotirucallane, named 25-dehydroxy protoxylogranatin B (10), were isolated from the mangrove plants Xylocarpus granatum, Xylocarp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhong-Ping, Luan, Zhi-Lin, Liu, Ruo-Xi, Zhang, Qun, Ma, Xiao-Chi, Shen, Li, Wu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315889/ https://www.ncbi.nlm.nih.gov/pubmed/30563240 http://dx.doi.org/10.3390/md16120488

Ejemplares similares

New apotirucallane-type triterpenoids from Chisocheton paniculatus
por: Zhang, Feng, et al.
Publicado: (2012)

Two new tirucallane triterpenoids from Aphanamixis grandifolia
por: Wang, Xiao-Ying, et al.
Publicado: (2012)

Cytotoxic Tirucallane Triterpenoids from Melia azedarach Fruits
por: Ntalli, Nikoletta G., et al.
Publicado: (2010)

Tirucallane Triterpenoids from the Stems and Stem Bark of Cornus walteri that Control Adipocyte and Osteoblast Differentiations
por: Lee, Seoung Rak, et al.
Publicado: (2018)

Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists
por: Finamore, Claudia, et al.
Publicado: (2023)

(-)-Leucophyllone, a Tirucallane Triterpenoid from Cornus walteri, Enhances Insulin Secretion in INS-1 Cells
por: Lee, Dahae, et al.
Publicado: (2021)

Promoter DNA Methylation of Farnesoid X Receptor and Pregnane X Receptor Modulates the Intrahepatic Cholestasis of Pregnancy Phenotype
por: Cabrerizo, Romina, et al.
Publicado: (2014)

Antiparasitic Activity of Natural and Semi-Synthetic Tirucallane Triterpenoids from Schinus terebinthifolius (Anacardiaceae): Structure/Activity Relationships
por: Morais, Thiago R., et al.
Publicado: (2014)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor
por: Bartolini, Desirée, et al.
Publicado: (2020)

The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species
por: Krasowski, Matthew D, et al.
Publicado: (2011)

Two New Apotirucallane-Type Triterpenoids from the Pericarp of Toona sinensis and Their Ability to Reduce Oxidative Stress in Rat Glomerular Mesangial Cells Cultured under High-Glucose Conditions
por: Liu, Di, et al.
Publicado: (2020)

Biosynthetic pathway for furanosteroid demethoxyviridin and identification of an unusual pregnane side-chain cleavage
por: Wang, Gao-Qian, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

The role of pregnane X receptor (PXR) in substance metabolism
por: Lv, Ye, et al.
Publicado: (2022)

Evaluation of Computational Docking to Identify Pregnane X Receptor Agonists in the ToxCast Database
por: Kortagere, Sandhya, et al.
Publicado: (2010)

Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study
por: Erken, Robin, et al.
Publicado: (2021)

Cytotoxic and Antiviral Triterpenoids from the Mangrove Plant Sonneratia paracaseolaris
por: Gong, Kai-Kai, et al.
Publicado: (2017)

Cytotoxic Activity of Inositol Angelates and Tirucallane-Type Alkaloids from Amoora Dasyclada
por: Yang, Sheng-Xiang, et al.
Publicado: (2020)

Anti-inflammatory and Antiphytopathogenic Fungal Activity of 2,3-seco-Tirucallane Triterpenoids Meliadubins A and B from Melia dubia Cav. Barks with ChemGPS-NP and In Silico Prediction
por: Trung, Hieu Tran, et al.
Publicado: (2023)

The effect of Farnesoid X receptor agonist tropifexor on liver damage in rats with experimental obstructive jaundice
por: Kilavuz, Huseyin, et al.
Publicado: (2021)

Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Pregnane X receptor agonist nomilin extends lifespan and healthspan in preclinical models through detoxification functions
por: Fan, Shengjie, et al.
Publicado: (2023)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

Evolution of pharmacologic specificity in the pregnane X receptor
por: Ekins, Sean, et al.
Publicado: (2008)

Gut Microbes Take It to the Next Level? First Insights Into Farnesoid X Receptor Agonists of Microbial Origin
por: Lenicek, Martin, et al.
Publicado: (2020)

Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist
por: He, Handan, et al.
Publicado: (2023)

Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist
por: Rashidian, Azam, et al.
Publicado: (2022)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Functional evolution of the vitamin D and pregnane X receptors
por: Reschly, Erica J, et al.
Publicado: (2007)

Marine Ligands of the Pregnane X Receptor (PXR): An Overview
por: Carazo, Alejandro, et al.
Publicado: (2019)

Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
por: Skandalaki, Aikaterini, et al.
Publicado: (2021)

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis
por: Namisaki, Tadashi, et al.
Publicado: (2017)

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
por: Hu, Ying-Bin, et al.
Publicado: (2018)

Assessment of drug–drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects
por: Ahmad, Alaa, et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers
por: Younis, Islam R., et al.
Publicado: (2023)

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis
por: Schramm, Christoph, et al.
Publicado: (2022)

Sesquiterpenes Are Agonists of the Pregnane X Receptor but Do Not Induce the Expression of Phase I Drug-Metabolizing Enzymes in the Human Liver
por: Šadibolová, Michaela, et al.
Publicado: (2019)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Caenorhabditis Intervention Testing Program: the farnesoid X receptor agonist obeticholic acid does not robustly extend lifespan in nematodes
por: Morshead, Mackenzie L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g88mtip6n2sto5k4mg9t9hbim1